Regenerex Pharma, Inc. (RGPX) — 10-Q Filings

10-Q Filings (6)

• Regenerex Pharma's Losses Mount, Cash Dries Up Amidst No Revenue — Nov 17, 2025 Risk: high
  REGENEREX PHARMA, INC. (RGPX) reported a significant increase in net loss for the six months ended September 30, 2025, reaching $1,477,596, a substantial rise f
• Regenerex Pharma's Net Loss Soars 143% Amid Zero Revenue — Aug 14, 2025 Risk: high
  REGENEREX PHARMA, INC. (RGPX) reported a significant increase in net loss for the three months ended June 30, 2025, reaching $663,584, a substantial rise from t
• Regenerex Pharma Files Q3 2024 10-Q — Feb 7, 2025 Risk: low
  Regenerex Pharma, Inc. filed its quarterly report for the period ending December 31, 2024. The company, formerly known as Peptide Technologies, Inc. and Eternel
• Regenerex Pharma Files Q3 2024 10-Q — Nov 4, 2024 Risk: low
  Regenerex Pharma, Inc. filed its quarterly report for the period ending September 30, 2024. The company, previously known as Peptide Technologies, Inc. and Eter
• Regenerex Pharma Files Q2 2024 10-Q — Aug 7, 2024 Risk: medium
  Regenerex Pharma, Inc. filed its quarterly report for the period ended June 30, 2024. The company, previously known as Peptide Technologies, Inc. and Eternelle
• Regenerex Pharma, Inc. Files 10-Q for Period Ended December 31, 2023 — Feb 5, 2024 Risk: low
  REGENEREX PHARMA, INC. (RGPX) filed a Quarterly Report (10-Q) with the SEC on February 5, 2024. Regenerex Pharma, Inc. filed a 10-Q report for the period ending

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX